Testing the effect of metformin on breast cancer risk features

The purpose of this study is to see if taking metfomin can affect some of the risk factors associated with breast cancer, such as breast density, certain proteins and hormones, certain metabolites produced in the body, body weight, waist and hip sizes.

Primary disease category: Cancer

Secondary disease categories: Breast Cancer, Prevention

Sponsor: NCI/DCP

Projected enrollment dates: May 2014 to December 2019

Official study title: Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk